The Future of Cardiovascular Imaging in the Diagnosis and Management of Heart Failure, Part 2: Clinical Applications

Received July 29, 2008; accepted July 29, 2008. Part 1 of these articles focused on the targets of the imaging examination in heart failure (HF) and also reviewed the individual techniques that might be used to address these features.1 This article will concentrate on specific clinical situations. Despite improvements in outcomes related to new treatments for HF, the prognosis of this condition remains poor. The guidelines of the American College of Cardiology and the American Heart Association have emphasized the importance of the detection of early disease in patients at risk (stage A) and those with asymptomatic evidence of left ventricular (LV) damage (stage B).2 The identification of these entities should lead to the initiation of prophylactic therapy. In those already on therapy (eg, antihypertensive drugs), the detection of target organ disease (eg, LV hypertrophy) may justify more intensive therapy. ### Early Detection of HF Despite interest in biomarkers, imaging seems to be the optimal strategy for HF screening. It is likely that this will be performed in the community and it is probable (because of cost and availability considerations) that the test of choice will remain echocardiography.3 The increasing workload provided by the HF epidemic may alter the workflow, with an increasing role for imaging in primary care. Although the wider use of echocardiography by noncardiologists will bring challenges with respect to training, this process will be facilitated by progressive miniaturization and automation, which will allow better quantification and reduced subjectivity. The subjective assessment of echocardiography is a well-recognized limitation that has been improved, but not avoided, by modern technical developments. The availability of a simple quantitative parameter to support the clinician’s interpretation of resting echocardiographic images may be provided by the assessment of 2D myocardial strain, based on speckle tracking, although it remains to be shown to what extent the …

[1]  C. Caussin,et al.  Non-invasive diagnosis of ischaemic heart failure using 64-slice computed tomography. , 2008, European heart journal.

[2]  F. Prinzen,et al.  Mechanical discoordination rather than dyssynchrony predicts reverse remodeling upon cardiac resynchronization. , 2008, American journal of physiology. Heart and circulatory physiology.

[3]  M. Schwaiger,et al.  The Future of Cardiovascular Imaging in the Diagnosis and Management of Heart Failure, Part 1: Tasks and Tools , 2008, Circulation. Cardiovascular imaging.

[4]  Jeroen J. Bax,et al.  Results of the Predictors of Response to CRT (PROSPECT) Trial , 2008, Circulation.

[5]  W. McKenna,et al.  Left ventricular noncompaction and cardiomyopathy: cause, contributor, or epiphenomenon? , 2008, Current opinion in cardiology.

[6]  Richard Sutton,et al.  [Guidelines for cardiac pacing and cardiac resynchronization therapy]. , 2008, Revista portuguesa de cardiologia : orgao oficial da Sociedade Portuguesa de Cardiologia = Portuguese journal of cardiology : an official journal of the Portuguese Society of Cardiology.

[7]  J. Schulz-Menger,et al.  Delayed enhancement cardiac magnetic resonance imaging reveals typical patterns of myocardial injury in patients with various forms of non-ischemic heart disease , 2008, The International Journal of Cardiovascular Imaging.

[8]  Randy Martin,et al.  Echocardiography for cardiac resynchronization therapy: recommendations for performance and reporting--a report from the American Society of Echocardiography Dyssynchrony Writing Group endorsed by the Heart Rhythm Society. , 2008, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[9]  T. Marwick,et al.  Performance of conventional echocardiographic parameters and myocardial measurements in the sequential evaluation of left ventricular function. , 2008, The American journal of cardiology.

[10]  P. Schauerte,et al.  Impact of left ventricular lead position in cardiac resynchronization therapy on left ventricular remodelling. A circumferential strain analysis based on 2D echocardiography. , 2008, European heart journal.

[11]  J. Mackey,et al.  Cardiac management during adjuvant trastuzumab therapy: recommendations of the Canadian Trastuzumab Working Group , 2008, Current oncology.

[12]  P. Tchou,et al.  Cardiac-resynchronization therapy in heart failure with narrow QRS complexes. , 2007, The New England journal of medicine.

[13]  D. Pennell,et al.  Myocardial late gadolinium enhancement in specific cardiomyopathies by cardiovascular magnetic resonance: a preliminary experience , 2007, Journal of cardiovascular medicine.

[14]  K. Dickstein,et al.  How to diagnose diastolic heart failure: a consensus statement on the diagnosis of heart failure with normal left ventricular ejection fraction by the Heart Failure and Echocardiography Associations of the European Society of Cardiology. , 2007, European heart journal.

[15]  Richard Sutton,et al.  Guidelines for cardiac pacing and cardiac resynchronization therapy. The Task Force for Cardiac Pacing and Cardiac Resynchronization Therapy of the European Society of Cardiology. Developed in collaboration with the European Heart Rhythm Association. , 2007, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[16]  J. Kirkpatrick,et al.  Echocardiography in heart failure: applications, utility, and new horizons. , 2007, Journal of the American College of Cardiology.

[17]  J L Hare,et al.  Feasibility and clinical decision-making with 3D echocardiography in routine practice , 2007, Heart.

[18]  Paul Heidenreich,et al.  ACCF/ASE/ACEP/ASNC/SCAI/SCCT/SCMR 2007 appropriateness criteria for transthoracic and transesophageal echocardiography: a report of the American College of Cardiology Foundation Quality Strategic Directions Committee Appropriateness Criteria Working Group, American Society of Echocardiography, Ameri , 2007, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[19]  N. Bellenger,et al.  Ischaemic and non-ischaemic cardiomyopathies--cardiac MRI appearances with delayed enhancement. , 2007, Clinical radiology.

[20]  Jeroen J. Bax,et al.  Role of imaging in cardiac stem cell therapy. , 2007, Journal of the American College of Cardiology.

[21]  P. Collinson,et al.  Cost Effectiveness of the B Type Natriuretic Peptide, Electrocardiography, and Portable Echocardiography for the Assessment of Patients from the Community with Suspected Heart Failure , 2007, Echocardiography.

[22]  Jeroen J. Bax,et al.  Impact of viability and scar tissue on response to cardiac resynchronization therapy in ischaemic heart failure patients. , 2006, European heart journal.

[23]  Mark A Westwood,et al.  Randomized controlled trial of deferiprone or deferoxamine in beta-thalassemia major patients with asymptomatic myocardial siderosis. , 2006, Blood.

[24]  T. Marwick Measurement of strain and strain rate by echocardiography: ready for prime time? , 2006, Journal of the American College of Cardiology.

[25]  Maxime Cannesson,et al.  Novel Speckle-Tracking Radial Strain From Routine Black-and-White Echocardiographic Images to Quantify Dyssynchrony and Predict Response to Cardiac Resynchronization Therapy , 2006, Circulation.

[26]  R. Hendel,et al.  ACCF proposed method for evaluating the appropriateness of cardiovascular imaging. , 2005, Journal of the American College of Cardiology.

[27]  M. Sabatier,et al.  Endoventricular Patch Reconstruction of Ischemic Failing Ventricle. A Single Center with 20 years Experience. Advantages of Magnetic Resonance Imaging Assessment , 2005, Heart Failure Reviews.

[28]  Christophe Leclercq,et al.  Cardiac Dyssynchrony Analysis Using Circumferential Versus Longitudinal Strain: Implications for Assessing Cardiac Resynchronization , 2005, Circulation.

[29]  J. Daubert,et al.  Baseline characteristics of patients recruited into the CARE‐HF study , 2005, European journal of heart failure.

[30]  D. Pennell,et al.  Myocardial iron clearance during reversal of siderotic cardiomyopathy with intravenous desferrioxamine: a prospective study using T2* cardiovascular magnetic resonance , 2004, British journal of haematology.

[31]  T. Marwick,et al.  Reproducibility and accuracy of echocardiographic measurements of left ventricular parameters using real-time three-dimensional echocardiography. , 2004, Journal of the American College of Cardiology.

[32]  R. Troughton,et al.  NT‐proBNP in heart failure: therapy decisions and monitoring , 2004, European journal of heart failure.

[33]  Edmund Kenneth Kerut,et al.  Review of Methods for Texture Analysis of Myocardium From Echocardiographic Images: A Means of Tissue Characterization , 2003, Echocardiography.

[34]  C H Lorenz,et al.  Differentiation of Heart Failure Related to Dilated Cardiomyopathy and Coronary Artery Disease Using Gadolinium‐Enhanced Cardiovascular Magnetic Resonance , 2003, Circulation.

[35]  D. Pennell,et al.  Toward clinical risk assessment in hypertrophic cardiomyopathy with gadolinium cardiovascular magnetic resonance. , 2003, Journal of the American College of Cardiology.

[36]  R. Kerber,et al.  ACC/AHA/NASPE 2002 guideline update for implantation of cardiac pacemakers and antiarrhythmia devices: summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/NASPE Committee to Update the 1998 Pacemaker Guidelines). , 2002, Circulation.

[37]  D N Firmin,et al.  Cardiovascular T2-star (T2*) magnetic resonance for the early diagnosis of myocardial iron overload. , 2001, European heart journal.

[38]  M. Quiñones,et al.  Tissue Doppler Imaging Consistently Detects Myocardial Abnormalities in Patients With Hypertrophic Cardiomyopathy and Provides a Novel Means for an Early Diagnosis Before and Independently of Hypertrophy , 2001, Circulation.

[39]  A. Fraser,et al.  Differentiation between pathologic and physiologic left ventricular hypertrophy by tissue Doppler assessment of long-axis function in patients with hypertrophic cardiomyopathy or systemic hypertension and in athletes. , 2001, The American journal of cardiology.

[40]  G R Sutherland,et al.  Differences in myocardial velocity gradient measured throughout the cardiac cycle in patients with hypertrophic cardiomyopathy, athletes and patients with left ventricular hypertrophy due to hypertension. , 1997, Journal of the American College of Cardiology.

[41]  G. Sinagra,et al.  Persistence of restrictive left ventricular filling pattern in dilated cardiomyopathy: an ominous prognostic sign. , 1997, Journal of the American College of Cardiology.

[42]  I. Holme,et al.  Accuracy and reproducibility of biplane two-dimensional echocardiographic measurements of left ventricular dimensions and function. , 1997, European heart journal.

[43]  J. Gottdiener,et al.  Should echocardiography be performed to assess effects of antihypertensive therapy? Test-retest reliability of echocardiography for measurement of left ventricular mass and function. , 1995, Journal of the American College of Cardiology.

[44]  J. Griffith,et al.  Predicting recovery of severe regional ventricular dysfunction. Comparison of resting scintigraphy with 201Tl and 99mTc-sestamibi. , 1994, Circulation.

[45]  J. Mason,et al.  Guidelines for implantation of cardiac pacemakers and antiarrhythmia devices. A report of the American College of Cardiology/American Heart Association Task Force on Assessment of Diagnostic and Therapeutic Cardiovascular Procedures (Committee on Pacemaker Implantation). , 1991, Journal of the American College of Cardiology.

[46]  Michael Becker,et al.  Myocardial strain measurement with 2-dimensional speckle-tracking echocardiography: definition of normal range. , 2009, JACC. Cardiovascular imaging.

[47]  O. Rimoldi,et al.  Stunning, Hibernation, and Assessment of Myocardial Viability , 2008, Circulation.

[48]  J. Ornato,et al.  ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult—Summary Article , 2005 .

[49]  James B Seward,et al.  Risks for atrial fibrillation and congestive heart failure in patients >/=65 years of age with abnormal left ventricular diastolic relaxation. , 2004, The American journal of cardiology.

[50]  D J Pennell,et al.  Reduction in sample size for studies of remodeling in heart failure by the use of cardiovascular magnetic resonance. , 2000, Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance.